Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Pathol Oncol Res

Search In Journal Title:

Abbravation: Pathology & Oncology Research

Search In Journal Abbravation:

Publisher

Springer Netherlands

Search In Publisher:

DOI

10.1016/1011-1344(95)07185-7

Search In DOI:

ISSN

1532-2807

Search In ISSN:
Search In Title Of Papers:

The Expression of High Mobility Group Box 1 is Ass

Authors: Chen Chuangui Tang Peng Yu Zhentao
Publish Date: 2012/04/29
Volume: 18, Issue: 4, Pages: 1021-1027
PDF Link

Abstract

The objective is to explore the expression of high mobility group box 1 HMGB1 in esophageal squamous cell carcinoma ESCC and its relationship with lymph node metastasis and the prognosis of patients as well as possible mechanism The expression of HMGB1 vascular endothelial growth factor C VEGFC and lymphatic vessel endothelial hyaluronan receptor 1 LYVE1 in ESCC tissues which were obtained from 72 patients who underwent radical esophagectomy was detected through immunohistochemistry firstly The correlations between HMGB1 and VEGFC and microlymphatic vessel density MLD and lymph node metastasis and the prognosis of patients were analyzed by statistic analysis The plasmid of small interference RNA siRNA targeting HMGB1 giving siHMGB1 was transfected into exponentially growing KYSE150 human esophageal squamous cancer cells and the expression of HMGB1 mRNA and protein was observed by Realtime PCR and Western Blot and the expression of VEGFC was examined by ELISA HMGB1 expressed highly in the nuclei and cytoplasm of carcinoma cells as well as the extracellular space in ESCC and was associated with lymph node metastasis MLD the expression of VEGFC TNM stage and the prognosis of patients P  005 or P  001 In vitro siHMGB1 inhibited the expression of HMGB1 mRNA and protein and the secretion of VEGFC in KYSE150 cells In ESCC HMGB1 expresses highly and affects the prognosis of patients through regulating the expression of VEGFC to promote lymphangiogenesis and lymph node metastasis and HMGB1 might serve as the marker of progression and potential target for antilymphangiogenesis therapy


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Clinico-Pathological Particularities of the Shock-Related Pancreatitis
  2. Lymphoproliferative Disorders After Solid Organ Transplantation—Classification, Incidence, Risk Factors, Early Detection and Treatment Options
  3. Tumor Grade versus Expression of Invasion-Related Molecules in Astrocytoma
  4. Primary Adamantinoma of the Rib. Unusual Presentation for a Bone Neoplasm of Uncertain Origin
  5. Neuroendocrine Tumors of Extrahepatic Biliary Tract
  6. Frameshift Mutations of SMG7 Essential for Nonsense-Mediated mRNA Decay in Gastric and Colorectal Cancers
  7. K-ras Mutation, HPV Infection and Smoking or Alcohol Abuse Positively Correlate with Esophageal Squamous Carcinoma
  8. Claudin-1 as a Biomarker of Cervical Cytology and Histology
  9. Adult Extrarenal Wilms’ Tumor Mimicking Mixed Epithelial and Stromal Tumor in the Retroperitoneum: A Case Report with Immunohistochemical Study and Review of the Literature
  10. Entire-volume Serial Histological Examination for Detection of Micrometastases in Lymph Nodes of Colorectal Cancers
  11. Expression of TGFβ1 and Its Signaling Components by Peripheral Lymphocytes in Systemic Lupus Erythematosus
  12. Diagnostic Concordance in Reporting Breast Needle Core Biopsies using the B Classification—A Panel in Italy
  13. Expression and Clinical Significance of FAK and Src Proteins in Human Endometrial Adenocarcinoma
  14. Subcutaneous Calcification as a Delayed Complication of Radiotherapy: A Case Report and Review of the Literature
  15. Expression of Matrilin-2 in Liver Cirrhosis and Hepatocellular Carcinoma
  16. Reversing Multidrug-Resistant by RNA Interference Through Silencing MDR1 Gene in Human Hepatocellular Carcinoma Cells Subline Bel-7402/ADM
  17. Genetic Polymorphism of XRCC1 Correlated with Response to Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer
  18. Polymorphism of UBC9 Gene Encoding the SUMO-E2-Conjugating Enzyme and Breast Cancer Risk
  19. Variations in EGFR ctDNA Correlates to the Clinical Efficacy of Afatinib in Non Small Cell Lung Cancer with Acquired Resistance
  20. Meta-Analysis for the Therapeutic Effect of Neoadjuvant Therapy in Resectable Esophageal Cancer
  21. Phenotypical Characteristics of the Immune Cells in Allergic Contact Dermatitis, Atopic Dermatitis and Pityriasis Rosea
  22. Tumor Preventive Efficacy of Emodin in 7,12-Dimethylbenz[a]Anthracene-Induced Oral Carcinogenesis: a Histopathological and Biochemical Approach
  23. Serum Vascular Endothelial Growth Factors A, C and D in Human Breast Tumors
  24. 4-1BB Protects Dendritic Cells from Prostate Cancer-Induced Apoptosis
  25. Biologic Evaluation of Diabetes and Local Recurrence in Non-Small Cell Lung Cancer
  26. Autologous Dendritic Cell Based Adoptive Immunotherapy of Patients with Colorectal Cancer—A Phase I-II Study

Search Result: